title: Poor immediate tolerability of amphotericin B lipid emulsion in patients with haematological malignancies. Haematology-Microbiology Group.
authors.forename: M
authors.initials: M
authors.lastname: Laverdière
authors.forename: F
authors.initials: F
authors.lastname: Habel
authors.forename: K
authors.initials: K
authors.lastname: Weiss
authors.forename: J
authors.initials: J
authors.lastname: Delorme
authors.forename: G
authors.initials: G
authors.lastname: Dubois
authors.forename: N
authors.initials: N
authors.lastname: Gagnon
authors.forename: R
authors.initials: R
authors.lastname: Bélanger
mesh_terms: D000666:Amphotericin B / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001794:Blood Pressure / Q000187:drug effects; D005217:Fat Emulsions, Intravenous / Q000009:adverse effects*; D005334:Fever / Q000139:chemically induced; D006339:Heart Rate / Q000187:drug effects; D019337:Hematologic Neoplasms / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D009181:Mycoses / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000935:Antifungal Agents; D000970:Antineoplastic Agents; D005217:Fat Emulsions, Intravenous; D000666:Amphotericin B